Return to homepagePandemic Pact

Untersuchung zur wiederholten Seroprävalenz von Anti-SARS-CoV-2-IgG-Antikörpern in der Bevölkerung des Kantons Genf [Translation: Observational study of repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in the population of the canton of Geneva]

  • Funded by Federal Office of Public Health (FOPH)
  • Total publications:0 publications

Grant number: 20.007826

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Known Financial Commitments (USD)

    $197,760

  • Funder

    Federal Office of Public Health (FOPH)

  • Principal Investigator

    Brigitte Meier

  • Research Location

    Switzerland

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Hospital personnel

Abstract

General knowledge on the epidemiology (seroprevalence) of CoV-19 as well as specific knowledge on the exposure and risk to health workers by monitoring symptoms should be obtained. These findings are of the greatest relevance for all hospitals in Switzerland, not least with a view to the deployment planning of health personnel.